Tumor-derived lncRNAs: Behind-the-scenes mediators that modulate the immune system and play a role in cancer pathogenesis

Pathol Res Pract. 2024 Feb:254:155123. doi: 10.1016/j.prp.2024.155123. Epub 2024 Jan 11.

Abstract

Having been involved in complex cellular regulatory networks and cell-to-cell communications, non-coding RNAs (lncRNAs) have become functional carriers that transmit information between cells and tissues, modulate tumor microenvironments, encourage angiogenesis and invasion, and make tumor cells more resistant to drugs. Immune cells' exosomal lncRNAs may be introduced into tumor cells to influence the tumor's course and the treatment's effectiveness. Research has focused on determining if non-coding RNAs affect many target genes to mediate regulating recipient cells. The tumor microenvironment's immune and cancer cells are influenced by lncRNAs, which may impact a treatment's efficacy. The lncRNA-mediated interaction between cancer cells and immune cells invading the tumor microenvironment has been the subject of numerous recent studies. On the other hand, tumor-derived lncRNAs' control over the immune system has not gotten much attention and is still a relatively new area of study. Tumor-derived lncRNAs are recognized to contribute to tumor immunity, while the exact mechanism is unclear.

Keywords: Carcinogenesis; Immune cells-derived lncRNAs; Immune system; LncRNA; Tumor-derived lncRNAs.

Publication types

  • Review

MeSH terms

  • Humans
  • Immune System / pathology
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • RNA, Long Noncoding* / genetics
  • Tumor Microenvironment / genetics

Substances

  • RNA, Long Noncoding